Structure-activity relationship study of a series of N-substituted piperazinyl-flouroquinolones as anti-Helicobacter pylori agents

Medicinal Chemistry

Volumn 4, Issue 5, 2008, Pages 498-502

  Foroumadi, A ^a   Safavi, M ^a   Emami, S ^b   Siavoshi, F ^c   Najjari, S ^a   Safari, F ^c   Shafiee, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

7 piperazinyl quinolones; Antibacterial activity; Floroquinolones; Helicobacter pylori

Indexed keywords

CIPROFLOXACIN; ENOXACIN; METRONIDAZOLE; N (PHENETHYL)PIPERAZINYLQUINOLONE DERIVATIVE; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DISK DIFFUSION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HELICOBACTER PYLORI; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57349142510     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340608785700162     Document Type: Article

References (29)

1. Manabe, S.; Ishii, K.; Ito, Y. J. Org. Chem., 2007, 72, 6107.
2. Gisbert, J. P.; Gisbert, J. L.; Marcos, S.; Moreno-Otero, R.; Pajares, J. M. Helicobacter, 2007, 12, 68.
3. Chimenti, F.; Bizzarri, B.; Bolasco, A.; Secci, D.; Chimenti, P.; Carradori, S.; Granese, A.; Rivanera, D.; Lilli, D.; Zicari, A.; Scaltrito, M. M.; Sisto, F. Bioorg. Med. Chem. Lett., 2007, 17, 3065.
4. Chimenti, F.; Bizzarri, B.; Bolasco, A.; Secci, D.; Chimenti, P.; Carradori, S.; Granese, A.; Rivanera, D.; Lilli, D.; Scaltrito, M. M.; Brenciaglia, M. I. Eur. J. Med. Chem., 2006, 41, 208.
5. Chimenti, F.; Bizzarri, B.; Manna, F.; Bolasco, A.; Secci, D.; Chimenti, P.; Granese, A.; Rivanera, D.; Lilli, D.; Scaltrito, M. M.; Brenciaglia, M. I. Bioorg. Med. Chem. Lett., 2005, 15, 603.
6. Yoshida, Y.; Barrett, D.; Azami, H.; Morinaga, C.; Matsomoto, Y.; Takasugi, H. Bioorg. Med. Chem. Lett., 1998, 8, 1897.
7. Sharara, A. I.; Chaar, H. F.; Racoubian, E.; Moukhachen, O.; Barada, K. A.; Mourad, F. H.; Araj, G. F. Helicobacter, 2004, 9, 255.
8. Nishimori, I.; Minakuchi, T.; Kohsaki, T.; Onishi, S.; Takeuchi, H.; Vullo, D.; Scozzafavac, A.; Supuranc, C. T. Bioorg. Med. Chem. Lett., 2007, 17, 3585.
9. Bogaerts, P.; Berhin, C.; Nizet, H.; Glupczynski, Y. Helicobacter, 2006, 11, 441.
10. Antos, D.; Schneider-Brachert, W.; Bästlein, E.; Hanel, C.; Haferland, C.; Buchner, M.; Meier, E.; Trump, F.; Stolte, M.; Lehn, N.; Bayerdorfferâ, E. Helicobacter, 2006, 11, 39.
11. Gisbert, J. P.; Castro-Fernandez, M.; Bermejo, F.; Perez-Aisa, A.; Ducons, J.; Fernandez-Bermejo, M.; Bory, F.; Cosme, A.; Benito, L. M.; Lopez-Rivas, L.; Lamas, E.; Pabon, M.; Olivares, D. Am. J. Gastroenterol., 2006, 101, 243.
12. Gisbert, J. P.; Morena, F. Aliment. Pharmacol. Ther., 2006, 23, 35.
13. Wong, W. M.; Gu, Q.; Yee, Y. K.; Fung, F. M. Y.; Tong, T. S. M.; Chan, A. O. O.; Lai, K. C.; Chan, C. K.; Wong, B. C. Y. Aliment. Pharmacol. Ther., 2006, 23, 421.
14. Carbone, M.; Fera, M. T.; Cecchetti, V.; Tabarrini, O.; Losi, E.; Cusumano, V.; Teti, G. Antimicrob. Agents Chemother., 1997, 41, 2790.
15. von Rosenstiel, N.; Adam, D. Drugs, 1994, 47, 872.
16. Mitscher, L. A. Chem. Rev., 2005, 105, 559.
17. Anderson, V. E.; Osheroff, N. Curr. Pharmaceut. Des., 2001, 7, 339.
18. Hooper, D. C. Clin. Infect. Dis., 2001, 32, 9.
19. Fujimura, S.; Kato, S.; Iinuma, K.; Watanabe, A. J. Med. Microbiol., 2004, 53, 1019.
20. Tankovic, J.; Lascols, C.; Sculo, Q.; Petit, J. C.; Soussy, C. J. Antimicrob. Agents Chemother., 2003, 47, 3942.
21. Boyanova, L.; Mentis, A.; Gubina, M.; Rozynek, E.; Gosciniak, G.; Kalenic, S.; Göral, V.; Kupcinskas, L.; Kantarçeken, B.; Aydin, A.; Archimandritis, A.; Dzierzanowska, D.; Vcev, A.; Ivanova, K.; Marina, M.; Mitov, I.; Petrov, P.; Özden, A.; Popova, M. Clin. Microbiol. Infect., 2002, 8, 388.
22. Cattoir, V.; Nectoux, J.; Lascols, C.; Soussy, C.; Cambau, E., Helicobacter, 2005, 10, 542.
23. Kim, J. M.; Kim, J. S.; Kim, N.; Jung, H. C.; Song, I. S. J. Antimicrob. Chemother., 2005, 56, 965.
24. Foroumadi, A.; Emami, S.; Davood, A.; Moshafi, M. H.; Sharifian, A.; Tabatabaiee, M.; Tarhimi Farimani, H.; Sepehri, G.; Shafiee, A. Pharmaceut. Sci., 1997, 3, 559.
25. Foroumadi, A.; Ghodsi, S.; Emami, S.; Najjari, S.; Samadi, N.; Faramarzi, M. A.; Beikmohammadi, L.; Shirazi, F. H.; Shafiee, A. Bioorg. Med. Chem. Lett., 2006, 16, 3499.
26. Mirzaei, J.; Siavoshi, F.; Emami, S.; Safari, F.; Khoshayand, M. R.; Shafiee, A.; Foroumadi, A. Eur. J. Med. Chem., 2007, In Press: doi: 10.1016/j.ejmech.2007.11.019.
27. Domagala, J. M. J. Antimicrob. Chemother., 1994, 33, 685.
28. Tillotson, G. S.; Blondeau, J. M. In Moxifloxacin in Practice; Adam, D.; Finch, R. G.; Hunter, P. A., Eds.; Maxim Medical, 1999, pp. 91-101.
29. Asahina, Y.; Ishizaki, T.; Suzue, S. Prog. Drug Res., 1992, 38, 57.